China Small Molecule Active Pharmaceutical Ingredient Market Research Report 2018

February 2018 | 121 pages | ID: CFA36504795QEN
QYResearch

Abstracts

The global Small Molecule Active Pharmaceutical Ingredient market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Small Molecule Active Pharmaceutical Ingredient development status and future trend in China, focuses on top players in China, also splits Small Molecule Active Pharmaceutical Ingredient by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Johnson Matthey
• Siegfried Holding AG
• Pfizer
• Sanofi S.A.
• Novartis AG,
• Bristol-Myers Squibb
• Boehringer Ingelheim GmbH
• GlaxoSmithKline
• Albany Molecular Research Inc.
• Bachem Holding AG
• PCAS
• Patheon N.V.
• AstraZeneca
• Johnson & Johnson
• Merck & Co, Inc.
• BASF SE
• Catalent Inc.
• Teva Pharmaceuticals
• Roche
• Cambrex Corporation
• GILEAD Science Inc.

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• Standard API
• High Potency API

On the basis of the end users/application, this report covers

• Cardiovascular Diseases
• Respiratory Disorders
• Infectious Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Small Molecule Active Pharmaceutical Ingredient Market Research Report 2017

1 SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT OVERVIEW

1.1 Product Overview and Scope of Small Molecule Active Pharmaceutical Ingredient
1.2 Classification of Small Molecule Active Pharmaceutical Ingredient by Product Category
  1.2.1 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Comparison by Type (2012-2022)
  1.2.2 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Market Share by Type in 2016
  1.2.3 Standard API
  1.2.4 High Potency API
1.3 China Small Molecule Active Pharmaceutical Ingredient Market by Application/End Users
  1.3.1 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Cardiovascular Diseases
  1.3.3 Respiratory Disorders
  1.3.4 Infectious Diseases
  1.3.5 Others
1.4 China Small Molecule Active Pharmaceutical Ingredient Market by Region
  1.4.1 China Small Molecule Active Pharmaceutical Ingredient Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.3 East China Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.4 Southwest China Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.5 Northeast China Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.6 North China Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.7 Central China Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Small Molecule Active Pharmaceutical Ingredient (2012-2022)
  1.5.1 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2022)
  1.5.2 China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Small Molecule Active Pharmaceutical Ingredient Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Small Molecule Active Pharmaceutical Ingredient Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Small Molecule Active Pharmaceutical Ingredient Average Price (USD/Kg) by Players/Manufacturers (2012-2017)
2.4 China Small Molecule Active Pharmaceutical Ingredient Market Competitive Situation and Trends
  2.4.1 China Small Molecule Active Pharmaceutical Ingredient Market Concentration Rate
  2.4.2 China Small Molecule Active Pharmaceutical Ingredient Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT SALES AND REVENUE BY REGION (2012-2017)

3.1 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Market Share by Region (2012-2017)
3.2 China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Small Molecule Active Pharmaceutical Ingredient Price (USD/Kg) by Regions (2012-2017)

4 CHINA SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Small Molecule Active Pharmaceutical Ingredient Price (USD/Kg) by Type (2012-2017)
4.4 China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (%) by Type (2012-2017)

5 CHINA SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT SALES BY APPLICATION (2012-2017)

5.1 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Market Share by Application (2012-2017)
5.2 China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Johnson Matthey
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Siegfried Holding AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi S.A.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis AG,
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Boehringer Ingelheim GmbH
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Albany Molecular Research Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Bachem Holding AG
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 PCAS
6.12 Patheon N.V.
6.13 AstraZeneca
6.14 Johnson & Johnson
6.15 Merck & Co, Inc.
6.16 BASF SE
6.17 Catalent Inc.
6.18 Teva Pharmaceuticals
6.19 Roche
6.20 Cambrex Corporation
6.21 GILEAD Science Inc.

7 SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING COST ANALYSIS

7.1 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Type (2017-2022)
11.3 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Application (2017-2022)
11.4 China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.


List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Revenue (Million USD) Market Split by Product Type
Table Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2016-2022)
Figure Product Picture of Small Molecule Active Pharmaceutical Ingredient
Table China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share by Types in 2016
Figure Standard API Product Picture
Figure High Potency API Product Picture
Figure China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Small Molecule Active Pharmaceutical Ingredient by Application in 2016
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Respiratory Disorders Examples
Table Key Downstream Customer in Respiratory Disorders
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Small Molecule Active Pharmaceutical Ingredient Sales of Key Players/Manufacturers (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Players/Manufacturers
Figure 2017 China Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Players/Manufacturers
Table China Small Molecule Active Pharmaceutical Ingredient Revenue by Players/Manufacturers (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Players/Manufacturers
Table China Market Small Molecule Active Pharmaceutical Ingredient Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Small Molecule Active Pharmaceutical Ingredient Average Price of Key Players/Manufacturers in 2016
Figure China Small Molecule Active Pharmaceutical Ingredient Market Share of Top 3 Players/Manufacturers
Figure China Small Molecule Active Pharmaceutical Ingredient Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Category
Table China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Regions (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Regions (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Regions (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Regions in 2016
Table China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Regions (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Regions (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Regions in 2016
Table China Small Molecule Active Pharmaceutical Ingredient Price (USD/Kg) by Regions (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Type (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Type (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Type in 2016
Table China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Small Molecule Active Pharmaceutical Ingredient by Type (2012-2017)
Figure Revenue Market Share of Small Molecule Active Pharmaceutical Ingredient by Type in 2016
Table China Small Molecule Active Pharmaceutical Ingredient Price (USD/Kg) by Types (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (%) by Type (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Applications (2012-2017)
Table China Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Applications (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Application (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Application in 2016
Table China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (%) by Application (2012-2017)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (%) by Application (2012-2017)
Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Pfizer Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%)(2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) in China (2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) in China (2012-2017)
Table PCAS Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table AstraZeneca Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Merck & Co, Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table BASF SE Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Roche Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Small Molecule Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient
Figure Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Small Molecule Active Pharmaceutical Ingredient Major Players/Manufacturers in 2016
Table Major Buyers of Small Molecule Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Price (USD/Kg) Trend Forecast (2017-2022)
Table China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Type (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Type (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share Forecast by Type in 2022
Table China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Application (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share Forecast by Application in 2022
Table China Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Regions (2017-2022)
Table China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share Forecast by Regions (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share Forecast by Regions (2017-2022)
Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources